))
Dr. Nicola Mason | Immunotherapy Innovations
Manage episode 443805830 series 3561919
Conteúdo fornecido por ImpriMed, Inc.. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por ImpriMed, Inc. ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Mason, a leading figure in veterinary oncology and immunotherapy. Dr. Mason discusses her groundbreaking work at the University of Pennsylvania, where she leads the first canine cancer immunotherapy consortium backed by the Cancer Moonshot Initiative. With a background in immunology and extensive experience in developing innovative therapies for dogs with cancer, she highlights the importance of using canine models to better understand and accelerate human cancer treatments. The conversation delves into the complexities of tumor-immune system interactions, the evolution of immunotherapy, and exciting developments in off-the-shelf cellular therapies that could revolutionize treatment for both dogs and humans. Tune in to discover how veterinary science is paving the way for advancements in comparative oncology.
- PRE-medical Cancer Immunotherapy Network Canine Trials (PRECINCT): https://www.precinctnetwork.org/
- Vetigenics: https://vetigenics.com/
📝Transcripts are available at https://www.imprimedicine.com/podcast.
To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile
Music Credit: Hazy by Beat Mekanik
19 episódios
Compartilhar
